Loading clinical trials...
Loading clinical trials...
Chronic hepatitis C (CHC) is among the commonest chronic infectious disease in Australia with \>200,000 exposed persons. Amongst non-infectious chronic conditions- Type 2 diabetes, obesity and heart d...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Garvan Institute of Medical Research
NCT07415720 · Diabete Type 2, Obesity & Overweight, and more
NCT05543083 · Insulin Resistance, Depression, and more
NCT07403604 · Hyperinsulinemia, Insulin Resistance, and more
NCT07286747 · Prediabetes (Insulin Resistance, Impaired Glucose Tolerance)
NCT00001987 · Diabetes Mellitus, Severe Insulin Resistance
Garvan Institute Of Medical Research
Sydney, New South Wales
Storr Liver Unit
Sydney, New South Wales
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions